AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Byline: Luke Timmerman
Nov. 20--A few guys with a bold idea for a company is not the business story of 2002, but it's still happening in isolated spots.
It happened yesterday in Seattle's biotech scene. A new company called GeneCraft debuted by raising $13.6 million for what one of its founders, Ken Mohler, said was "a shared vision of the next great immunology company in Seattle."
GeneCraft has a long way to go to get there. It hasn't set up labs yet, isn't revealing the precise nature of its technology, and its talk about becoming the next Immunex is based heavily on its founders' scientific and managerial track records.
The company's co-founders include Peter Thompson as chief executive, Jeff Ledbetter as chief scientific …